Oura Pulls Nasdaq IPO Scheduled for This Week Citing Market Uncertainty

Smart ring maker Oura postponed its planned Nasdaq debut on Tuesday, September 29, citing uncertainty in the IPO market. The company had been set to list under the ticker OURA during the week of September 28, offering 50 million shares priced between $40 and $44 and targeting a fully diluted valuation of up to $15.6 billion.

The offering had been positioned as one of the most anticipated listings of the fall season. Oura and existing investors had planned to raise as much as $2.2 billion through the sale, with Eli Lilly indicating interest in purchasing up to $100 million of shares as part of a broader biometric-tracking partnership. The company reported $1.2 billion in revenue for the nine months ending June 30, 2026, up from $697 million in the same period a year earlier, and the deal was reported to be roughly four times oversubscribed before the delay was announced.

Oura's decision follows a string of other IPO withdrawals in recent weeks. Holtec Nuclear Corp. and Bamboo Insurance Services, backed by CVC Capital Partners, both postponed their listings, citing market conditions. Broader market jitters have been tied to uncertainty around the AI trade, rising bond yields and Federal Reserve rate policy, even as the S&P 500 had gained roughly 1.1% in September and the Nasdaq Composite had rallied more than 3% to a record high heading into the week.